活性成分市場：藥品、農業化學品、個人護理品和化妝品（按地區劃分），2024 年至 2031 年

2024 年至 2031 年活性成分市場評估

對活性成分的需求不斷增長，很大程度上是由於消費者對健康和保健產品的瞭解和偏好不斷增加。活性成分是藥品、化妝品、個人護理產品和其他健康相關商業產品的關鍵成分，在實現所需的治療或美容效果方面發揮關鍵作用。隨著人們健康意識的增強，對抗衰老、美白、增強免疫力等具有特殊功效的產品的需求將會增加，預計2024年銷售額將超過28.3億美元，2031年將達到41億美元。值將達到5000萬美元。

由於技術和科學的突破，活性成分市場正在擴大。生物技術、奈米技術和合成生物學的進步使得創造更有效的活性物質成為可能。例如，在皮膚護理中使用奈米技術可以提高活性化合物的吸收和功效。此外，製藥業務也不斷研究和開發新的活性成分，以滿足尚未滿足的醫療需求，例如治療慢性病、癌症和精神健康問題。因此，2024 年至 2031 年期間市場將以 4.90% 的複合年增長率成長。

活性成分市場定義/概述

活性成分是使產品正常發揮作用的關鍵成分。對於藥物而言，活性成分是直接治療或控制疾病或症狀的化學實體。例如，止痛藥布洛芬中的活性成分有助於減輕疼痛和發炎。活性化學物質可區分一種產品與另一種產品，並決定其功能。

活性成分是指產品中能產生預期效果的物質，無論是藥物、化妝品或農產品。在藥物中，活性成分是提供治療功效的主要成分。例如，就止痛藥而言，活性成分可能是布洛芬，它可以減輕發炎和疼痛。這些化學物質經過精心挑選，以針對特定的症狀和疾病，確保藥物的有效性。

未來活性化合物在醫藥、化妝品和農業領域的應用可能會取得突破。有效成分是藥物中發揮治療作用的主要部分。隨著生物技術和個人化醫療的進步，未來無疑將出現更多針對特定基因特徵量身定制的活性成分。這意味著，如果治療能夠根據每個人的生物組成進行定制，治療可能會更成功，副作用也更少。

在藥品製造上的廣泛使用是否會推動活性成分市場的發展？

活性成分在藥品製造上的廣泛使用是活性成分市場的主要驅動力。這一趨勢是由人口增長、預期壽命延長和慢性病增加等因素所推動的，全球對藥品的需求不斷增加。根據世界衛生組織（WHO）的數據，2018年全球衛生支出為8.3兆美元，佔全球GDP的10%。對醫療保健的大量投資增加了對藥品及其活性成分的需求。

根據美國食品藥物管理局（FDA）統計，2020年共有53種創新藥物獲得核准，彰顯製藥業的持續創新與成長。新型醫藥產品的不斷開發對活性成分產業的成長產生直接影響。藥品製造中活性成分的廣泛使用是活性成分市場發展的主要驅動力。這一趨勢是由人口增長、預期壽命延長和慢性病增加等因素所推動的，全球對藥品的需求不斷增加。根據世界衛生組織（WHO）的數據，2018年全球衛生支出為8.3兆美元，佔全球GDP的10%。對醫療保健的大量投資增加了對藥品及其活性成分的需求。根據美國食品藥物管理局（FDA）統計，2020年共有53種創新藥物獲得核准，顯示製藥業持續創新成長。新藥研發的推進對藥物成分產業的成長有直接的影響。

監理限制是否阻礙了活性成分市場？

監管限制可能會成為活性成分市場的一個重大障礙，阻礙其成長和發展。特別是在製藥和農業化學品行業，新的活性成分的嚴格審批流程構成了重大的監管障礙。根據美國食品藥物管理局（FDA）的數據，處理新藥申請的平均時間約為12個月，但一些更複雜的申請可能需要更長的時間。延長的時間可能會減慢創新產品的市場開發速度並增加公司的開發成本。

此外，歐洲藥品管理局 (EMA) 報告稱，新活性物質的平均評估時間約為 423 天，突顯了主要市場的監管週轉時間緩慢。另一個重要的監管限制是對環境和安全法規的日益重視。歐洲化學品管理局 (ECHA) 負責實施《化學品註冊、評估、授權和限制》(REACH)，要求企業註冊每年生產或進口數量超過一噸的任何化學物質。此外，美國環保署 (EPA) 報告稱，2020 財年完成了超過 22,000 種農藥產品審查，顯示對農藥業的監管十分嚴格。

目錄

第 1 章簡介

• 市場定義
• 市場區隔
• 研究方法

第 2 章執行摘要

• 主要發現 市場概況 市集亮點

第三章 市場概覽

• 市場規模與成長潛力
• 市場趨勢
• 市場推動因素
• 市場限制
• 市場機會
• 波特五力分析

第 4 章。

• 處方藥
• 非處方藥
• 生物製品

第 5 章：農藥有效成分市場

• 除草劑
• 殺蟲劑
• 殺菌劑
• 植物生長調節劑

第 6 章：個人護理和化妝品的活性成分市場

• 護膚產品
• 護髮產品
• 化妝品

第 7 章 區域分析

• 北美洲
• 美國
• 加拿大
• 墨西哥
• 歐洲
• 英國
• 德國
• 法國
• 義大利 亞太地區
• 中國
• 日本
• 印度
• 澳大利亞
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中東和非洲
• 南非
• 沙烏地阿拉伯
• 阿拉伯聯合大公國

第 8 章 市場動態

• 市場推動因素
• 市場限制
• 市場機會
• COVID-19 對市場的影響

第 9 章 競爭格局

• 大型公司
• 市佔率分析

第十章 公司簡介

• Pfizer
• Merck & Co.
• Roche
• Novartis
• Johnson & Johnson
• BASF SE
• Dow Chemical Company
• Evonik Industries
• Ashland Inc.
• Clariant

第 11 章 市場展望與機會

• 新興技術
• 未來市場趨勢
• 投資機會

第 12 章附錄

• 縮寫列表
• 來源與參考文獻

Active Ingredients Market Valuation - 2024-2031

The rising demand for active ingredients is largely due to increased customer knowledge and preference for health and wellness goods. Active ingredients which are critical components of medications, cosmetics, personal care products, and other health-related items play an important role in achieving the desired therapeutic or cosmetic outcome. As individuals grow more health-conscious, there is a greater demand for products that provide specialized benefits such as anti-aging, skin brightening, immune boosters, and other targeted impacts by enabling the market to surpass a revenue of USD 2.83 Billion valued in 2024 and reach a valuation of around USD 4.15 Billion by 2031.

The active ingredients market is expanding due to technological and scientific breakthroughs. Biotechnology, nanotechnology, and synthetic biology advancements have made it possible to create more potent and effective active substances. For example, using nanotechnology in skincare improves the absorption of active compounds, increasing their potency. Furthermore, the pharmaceutical business is always researching and developing novel active ingredients to meet unmet medical requirements such as therapies for chronic diseases, cancer, and mental health issues. This enables the market to grow at aCAGR of 4.90% from 2024 to 2031.

Active Ingredients Market: Definition/ Overview

Active ingredients are the key components of a product that allow it to work properly. In the case of pharmaceuticals, the active ingredient is a chemical component that directly treats or manages the symptoms of a disease or condition. For example, the active component in ibuprofen, a pain reliever is responsible for lowering pain and inflammation. Active chemicals distinguish one product from another and determine how it functions.

Active ingredients are substances in products that create the desired results whether in medications, cosmetics, or agricultural products. In medicines, active ingredients are the primary components that provide therapeutic advantages. For example, in pain relievers, the active ingredient may be ibuprofen which decreases inflammation and pain. These chemicals are carefully chosen to address specific symptoms or illnesses assuring the medication's efficacy.

The future usage of active compounds, notably in pharmaceuticals, cosmetics, and agriculture, is likely to be revolutionary as breakthroughs arise. Active ingredients are the primary components of medications that provide therapeutic effects. With advances in biotechnology and customized medicine, the future will most certainly see a trend toward more tailored active ingredients that cater to specific genetic profiles. This means that therapies may become more successful and have fewer negative effects if they are tailored to each individual's biological composition.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Will the Extensive Use in Drug Manufacturing Drive the Active Ingredients Market?

The extensive usage of active ingredients in medicine manufacture is a major driver of the active ingredients market. This trend is propelled by rising global demand for pharmaceuticals which is being driven by factors such as population expansion, longer life expectancy, and an increase in the prevalence of chronic diseases. According to the World Health Organization (WHO), worldwide health spending was USD 8.3 Trillion in 2018, accounting for 10% of global GDP. This significant investment in healthcare results in increasing demand for pharmaceuticals and, by extension, active ingredients.

The United States Food and Drug Administration (FDA) states that 53 innovative medications were approved in 2020 demonstrating the pharmaceutical industry's continued innovation and growth. The ongoing development of new pharmaceuticals has a direct impact on the growth of the active ingredients industry. The extensive usage of active ingredients in medicine manufacture is a major driver of the active ingredients market. This trend is propelled by rising global demand for pharmaceuticals which is being driven by factors such as population expansion, longer life expectancy, and an increase in the prevalence of chronic diseases. According to the World Health Organization (WHO), worldwide health spending was USD 8.3 Trillion in 2018 accounting for 10% of global GDP. This significant investment in healthcare results in increasing demand for pharmaceuticals and by extension, active ingredients. The United States Food and Drug Administration (FDA) states that 53 innovative medications were approved in 2020 demonstrating the pharmaceutical industry's continued innovation and growth. The ongoing development of new pharmaceuticals has a direct impact on the growth of the active ingredients industry.

Will the Regulatory Constraints Hamper the Active Ingredients Market?

Regulatory limits present important obstacles for the active ingredients market, potentially impeding its growth and development. The demanding clearance process for new active ingredients, notably in the pharmaceutical and agrochemical industries is a significant regulatory barrier. According to the United States Food and Drug Administration (FDA), the average time for approving a new drug application is about 12 months with some complex applications taking considerably longer. This prolonged timeline may delay market introduction for innovative items and increase the company's development expenses.

Furthermore, the European Medicines Agency (EMA) reports that the average period for evaluating a new active substance is approximately 423 days highlighting the time-consuming nature of regulatory compliance in key markets. Another key regulatory restraint is an increased emphasis on environmental and safety regulations. The European Chemicals Agency (ECHA) enforces the Registration, Evaluation, Authorization, and Restriction of Chemicals (REACH) law which requires enterprises to register chemical substances produced or imported in quantities of one tonne or more each year. Furthermore, the United States Environmental Protection Agency (EPA) reported completing over 22,000 pesticide product reviews in fiscal year 2020 indicating substantial regulatory monitoring in the agrochemical industry.

Category-Wise Acumens

Will a Wide Range of Serious and Chronic Medical Conditions Drive Growth in the Pharmaceutical Segment?

Prescription medications dominate because of their importance in treating a wide spectrum of serious and chronic medical disorders. Prescription medications contain active chemicals that have been precisely designed and approved for targeted therapies which are frequently used to treat complicated conditions such as cancer, cardiovascular difficulties, and autoimmune disorders. These active chemicals go through extensive research and clinical trials to confirm their efficacy and safety making them indispensable in modern medicine. The increased frequency of chronic diseases, an aging population, and ongoing innovation in medication development all contribute to prescription pharmaceutical supremacy.

Pharmaceutical companies invest extensively in research and development to generate new active components that can deliver more effective treatments with fewer side effects highlighting the importance of prescription pharmaceuticals. OTC medications and biological products play important roles in the market but they do not supplant prescription drugs. OTC medications while necessary for treating common and less severe illnesses, often contain well-established active components and do not require doctor supervision resulting in lower regulatory obstacles and research expenditure when compared to prescription drugs.

Will the Growing Consumer Awareness Drive the Personal Care and Cosmetics Segment?

Skincare goods segment is projected to dominate the market over the forecast period. This dominance is driven by increasing consumer awareness and concern about skin health, aging, and general skin look. Moisturizers, anti-aging creams, and treatments for acne and hyperpigmentation are becoming increasingly popular as customers prioritize preserving a young appearance and addressing specific skin ailments. The global increase in pollution, stress, and UV radiation has increased the demand for effective skincare solutions resulting in a spike in the discovery and application of new active ingredients.

Skincare's dominance in the active ingredients market is further bolstered by rising demand for multifunctional products that provide several advantages such as hydration, UV protection, and anti-aging qualities. As the world's population ages, there is a greater emphasis on anti-aging products which frequently attract higher prices due to their claimed efficacy and utilization of cutting-edge active ingredients. This has pushed businesses to invest extensively in R&D to innovate and create new active ingredients that can meet consumers changing wants.

Country/Region-wise Acumens

Will the Rising Prevalence of Preventable Chronic Diseases Drive the Market in the North American Region?

The growing frequency of avoidable chronic diseases in North America is primarily driving the market for active ingredients. This tendency is especially noticeable in the United States which accounts for a sizable chunk of the industry. The increasing frequency of chronic diseases in North America is a significant driver of the active ingredients market. According to the Centers for Disease Control and Prevention (CDC), six out of ten persons in the United States have a chronic disease with four out of ten having two or more chronic disorders. These astonishing figures underline the critical need for improved treatments and prevention strategies.

Chronic diseases impose an equal economic impact with the National Center for Chronic Disease Prevention and Health Promotion claiming that people with chronic and mental health conditions account for 90% of the nation's $3.8 trillion in yearly health care costs. This significant economic impact highlights the significance of treating chronic diseases and increases demand for active ingredients in medicines and nutraceuticals. The active ingredients market is also being boosted by the increased awareness of preventive healthcare measures among North Americans. The Healthy People 2030 effort launched by the United States Department of Health and Human Services seeks to reduce the burden of preventable diseases by encouraging health and wellness.

Will the Rapid Urbanization and an Expanding Middle-Class Population Drive the Market in the Asia Pacific Region?

The Asia Pacific region is witnessing the world's fastest urbanization rate with China and India leading the way. This fast urbanization combined with a rapidly rising middle-class population is expected to be a big driver of the region's active ingredients market. Urbanization in Asia Pacific is accelerating at an unprecedented rate. According to the United Nations Department of Economic and Social Affairs, Asia's urban population is expected to grow from 2.2 billion in 2020 to 3.5 billion in 2050. China alone is estimated to add 255 million urban residents between 2020 and 2050. This tremendous change to urban living is accompanied by changing lifestyles, higher disposable incomes, and heightened knowledge of personal care and health products.

Skincare's dominance in the active ingredients market is further bolstered by rising demand for multifunctional products that provide several advantages such as hydration, UV protection, and anti-aging qualities. As the world's population ages, there is a greater emphasis on anti-aging products which frequently attract higher prices due to their claimed efficacy and utilization of cutting-edge active ingredients. This has pushed businesses to invest extensively in R&D to innovate and create new active ingredients that can meet consumers' changing wants. Additionally, the rise of personalized skincare in which products are tailored to individual skin types and conditions has led to greater use of specific active ingredients that address unique concerns, further driving the market growth.

Competitive Landscape

The Active Ingredients Market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions, and political support. The organizations are focusing on innovating their product line to serve the vast population in diverse regions.

Some of the prominent players operating in the active ingredients market include:

BASF SE

The Dow Chemicals Company

Ashland, Inc.

Rhodia

Du Pont

Sumitomo Group

LOral S.A.

Beiersdorf AG

Sederma, Inc.

Evonik Industries

Latest Developments

In October 2020, Evonik significantly increased its bio-based line of active ingredients for the beauty and personal care industries in response to rising demand for innovative, sustainably sourced products.

In April 2021, Ashland announced a new active skin care component, claiming to enhance vibrancy and "glow" for a well-aged appearance.

TABLE OF CONTENTS

1.Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Active Ingredients Market, By Pharmaceuticals

• Prescription Drugs
• Over-the-Counter (OTC) Drugs
• Biological Products

5 Active Ingredients Market, By Agrochemicals

• Herbicides
• Insecticides
• Fungicides
• Plant Growth Regulators

6 Active Ingredients Market, By Personal Care and Cosmetics

• Skin Care Products
• Hair Care Products
• Cosmetics

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Pfizer
• Merck & Co.
• Roche
• Novartis
• Johnson & Johnson
• BASF SE
• Dow Chemical Company
• Evonik Industries
• Ashland Inc.
• Clariant

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References